Member Exclusive INTERVIEW

Commercialization of cell therapies – biopreservation’s make or break impact: an interview with Mike Rice

Mike Rice, CEO of NASDAQ traded BioLifeSolutions (WA, USA) explains the importance of biopreservation in commercializing regenerative medicine therapies and why funding for new cell-based therapies remains high.

Go to the profile of Freya Leask
Feb 09, 2017

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.